Over the past several years, evidence has accumulated demonstrating the existence of at least two T helper (Th) subpopulations involved in the activation of B lymphocytes. The evidence has come from several experimental systems that can be grouped into two major categories. The first category involves anti-hapten responses in which only the total response is followed without regard to particular B cell clones in the responding population. The second category involves anti-hapten responses characterized by a dominant, well-defined idiotype(s). In the former category, several laboratories (1-6) have shown that at least two subpopulations of Th cells are required for an optimum anti-hapten response. One population, Thl, requires the physical linkage of hapten to carrier, "cognate recognition" (2, 4-6) and appears to be an Ianegative population (3-6). The second population, Th2, does not require cognate recognition to function (2, 4-6), bears I region-encoded products (3-6), can be replaced by T cell replacing factors (TRF) (3, 5, 6), and in one system appears to recognize immunoglobulin (Ig) determinants in association with antigen (1).
(Calbiochem-Behring Corp., San Diego, CA) or ovalbumin (OVA) (Sigma Chemical Co., St. Louis, MO) emulsified in Freund's complete adjuvant to obtain carrier-specific T cells. B cells were primed intraperitoneally with 1.0/~g of TMA coupled to Escherichia coli lipopolysaccharide (LPS) (Sigma Chemical Co.) (12) . The hapten conjugates, TMA-KLH and TMA-OVA, were prepared as described (10) .
Preparation and Treatment of T Cells. 1 wk after immunization, nylon wool-passed T cells or immunosorbent nonadherent cells were treated with monoclonal anti-Lyt-2 antibodies and rabbit-anti-arsanilate affinity-purified antibodies (B-D FACS Systems, Becton, Dickinson & Co., Sunnyvale, CA) followed by treatment with low toxic rabbit complement (C) (Cedarlane Laboratories Ltd.). In some experiments, T cells were first treated with anti-Lyt-2 plus C, followed by a two-step treatment (I0 7 cells/ml) with anti-I-J antisera (1:10) and C (3). Anti-I-J antisera were prepared by immunizing B10.A (3R) mice with concanavalin A (Con A)-activated T blasts from B10.A (5R) mice as previously described (3) . Sera were exhaustively absorbed with cells from C57B1/6 J mice as described (3) .
Removal ofldiotype-specific T Cells. The method of Woodland and Cantor (7) was used, except that culture dishes were prepared with 200 #g of Na2SO4-precipitated normal A/J Ig or affinitypurified A/J anti-TMA antibody (60% Id ÷) (10) . Briefly, T cells (3 X 106 to 5 × 106 cells/ml) were incubated on plates for 40 min at 37°C, the nonadherent population collected, and the procedure repeated. Nonadherent cells (60-80% recovery) were then washed and treated with anti-Lyt-2 plus C.
Preparation of Con A Supernatants. Normal A/J spleen cells were cultured with Con A (4 #g/107 cells/ml) for 24 h at 37°C in complete media. The supernatant was collected, absorbed with Sephadex G-75, filter sterilized, and stored at -90~C until use (3) .
Preparation of B Cells. TMA-LPS-primed spleen cells were treated with anti-Thy-1 monoclonal antibody secreted by the hybridoma T24/40.7 (kindly provided by J. Kappler and P. Marrack, National Jewish Hospital, Denver, CO.) and C (3). Routinely, ~60% viable spleen cells were recovered.
Culture Conditions and Assay. Cells were cultured in RPMI 1640 (GIBCO Laboratories, Grand Island Biological Co., Grand Island NY) supplemented with 5% fetal calf serum, 25 mM Hepes, 5 X 10 -5 M 2-mercaptoethanol, penicillin, and streptomycin. Helper T cell activity was determined by titration into triplicate cultures containing 3 X 106 hapten-primed B cells, and 1 #g/ml of appropriate antigen was added. 4 d after culture, cells from identical wells were pooled and assayed for total anti-TMA plaque-forming cells (PFC) using TMA-substituted sheep erythrocytes (10) . Background PFC were detected using unsubstituted erythrocytes. CRI + PFC were determined by incorporating 10 #1 of anti-idiotypic antisera (anti-Id, 10 #g Idbinding capacity per ml) into the plaquing medium. The percent inhibition of PFC was calculated according to the formula: percent inhibition = ([1 -total PFC (anti-Id)]/total PFC) X 100 = percent CRI + PFC.
Results and Discussion
In a preliminary communication (13) we reported that at least two Lyt-l+,2 -Th populations are required to trigger anti-TMA PFC response in vitro, of which 40-80% produce a cross-reactive idiotype(s) (CRI-TMA). As seen in Table I culture (compare lines 3, 9, 13, 14, and 15). If, however, the same T-KLH population is first absorbed on CRI-coated dishes, thus removing potential Id-specific cells, they can no longer reconstitute the CRI ÷ PFC response in the presence of free KLH (data not shown). These results suggest the requirement of Id-specific Th2 and its activation by specific free carrier to obtain a PFC response dominated by CRI. Overall, these results suggest the participation of two classes of Th in activating TMA-specific B cells. This agrees well with other idiotype systems (7-9), which have similarly described the need for two Th. Tada et al. (4) have reported the existence of a Th subpopulation that is I-J + and does not require hapten linked to the carrier to function. To determine whether an I-J+ Th cell(s) was involved in the Id + TMA response, the Lyt-l+,2 -T-KLH were first treated with anti-I-J serum plus complement (C) before addition into culture. Our anti-I-J serum was produced against Con A T cell blasts, a method we have previously shown to induce highly T cell reactive anti-Ia sera (3). As seen in Table II , this treatment does not result in the loss of total TMA PFC, but there is a significant reduction in the percent CRI + PFC compartment (line 2). To determine the completeness of the anti-I-J serum treatment, the treated T cells were added up to 1 X 106 in culture with no increase in CRI + PFC (data not shown). To test whether it is the Th2 cells that bear I-J region gene products, the T-KLH were first treated with anti-I-J serum plus C before addition into cultures containing a T-OVA population depleted of Th2 cells. As in the previous experiment, this treatment did not reduce the total TMA response but did prevent the T-KLH from restoring the CRI + PFC (compare lines 4, 6, and 7). The possibility remained, however, that the Id-specific and the I-J + Th were separate synergizing populations, and the removal of either one from our T-KLH population would prevent restoration of the CRI + PFC. To rule this out, we mixed a population of T-KLH depleted of Id-specific cells (by plate absorption) with T-KLH depleted by anti-I-J plus C treatment. If separate populations existed, they would complement each other in this mixture. However, in * Nylon wool-passed T cells were first treated with anti-Lyt-2 plus C followed by treatment with anti-l-J sera plus C as described in Materials and Methods. Cultures were performed as in Table I . This table is representative of six similar experiments with the exception of the absorption experiment using B 10~A (5R) spleen cells which was performed once.
experiments not shown, this mixture failed to reconstitute an Id-depleted T-OVA population in the presence of TMA-OVA and KLH (similar to line 7). Lines 3 and 8 demonstrate the specificity of the antiserum because absorption with B10.A (5R) lymphocytes removes anti-I-J specific activity. Unlike removal of Th2 on CRI-coated plates, the removal of Th2 by anti-I-J treatment did not reduce the total TMA PFC. This might be explained by the removal of an I-J + suppressor inducer T cell for TMA. Such a T cell (I-J +, Lyt-1 +) has been described by others (14) but requires a Lyt-2 + cell for its expression. Such residual Lyt-2 + cells may contaminate either our T or B cell preparations. Overall, these results demonstrate that Th2 Id-specific cells bear I-J-encoded determinants and also define a new function and property of this cell type, i.e., its requirement for optimal CRI + PFC formation and the apparent existence of surface receptors with specificity for Ig idiotypes. Whether this latter property is universal for all Th2 cells involved in antihapten antibody responses remains unknown. We (3) and others (5) have described a Th2 population that bears surface Ia antigens and can be replaced by cell-free supernatants from in vitro 24-h Con Astimulated splenic lymphocytes. To test whether such supernatants could replace the Id-specific, I-J + Th2 cells, A/J spleen cells were stimulated with Con A for 24 h and the cell-free supernatant media (Con ASn) harvested. Con ASn was added to cultures depleted of Th2 activity by either anti-I-J + C treatment or absorption on CRI + coated plates. As seen in Table III , Con ASn added to intact cultures has no significant effect (lines 4 and 9) but clearly restores the CRI + PFC response in cultures that have been depleted of Th2 activity (lines 6 and 11). These results suggest that Con ASn can replace the Th2 cell. However, it could be argued that certain T cell growth factors in the Con ASn amplify the few remaining Th2 cells that may have not been removed after the antiserum or plate-absorption procedures. This is unlikely, as the supernatant from a T cell hybridoma, FS6-14.13 (kindly provided by Dr. J. Kappler and Dr. P. Marrack), which produces T cell growth factor but has no T cellreplacing activity for antibody responses (15), does not substitute for the idiotypespecific Th2 in our hands (data not shown). Moreover, Con ASn originating from certain non-H-2 a strains does not reconstitute the response (data not shown), a restriction we have so far observed only for idiotype-specific responses. It should be noted in Table III (line 2) that B cells alone in the presence of antigen plus Con ASn are not activated to CRI + TMA PFC above background, indicating the necessity for Thl cells in addition to Th2 activity.
In conclusion, the results demonstrate that the Th2 cell necessary for the expression of a dominant Id(s) also shares characteristics of Tb2 cells described in systems where idiotypes are not characterized. Namely, the Id-specific Th2 cell bears surface I-Jencoded Ia antigens and can be replaced with cell-free supernatant media from 24-h Con A-stimulated spleen cells. The latter findings suggest the effect of Th2 on CRI ÷ antibody-producing cells can be mediated by secreted T cell factors. Summary An in vitro system for the study of idiotype (Id) expression on antitrimethylamino hapten antibody-producing cells and its regulation by two classes of helper T cells is described. These cells are distinguished in four ways: one requires a hapten-carrier bridge and gives a good response that is low in Id; it does not bind to Id-coated dishes and is not affected by anti-I-J plus complement. The other requires antigen but not a hapten-carrier bridge, is bound by Id-coated dishes and is killed by anti-I-J and complement. The Id-specific cell appears to be antigen specific and acts via a soluble factor(s).
